The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Post-transcriptional Regulation of α-Synuclein Expression by mir-7 and mir-153
Abstract
Genetic and biochemical studies have established a central role for alpha-synuclein accumulation in the pathogenesis of Parkinson disease. Here, two microRNAs, namely mir-7 and mir-153, have been identified to regulate alpha-synuclein levels post-transcriptionally. These microRNAs bind specifically to the 3'-untranslated region of alpha-synuclein and down-regulate its mRNA and protein levels, with their effect being additive. They are expressed predominantly in the brain with a pattern that mirrors synuclein expression in different tissues as well as during neuronal development, indicating that they play a tuning role in the amount of alpha-synuclein produced. Overexpression of mir-7 and mir-153 significantly reduces endogenous alpha-synuclein levels, whereas inhibition of mir-7 and mir-153 enhances translation of a luciferase construct bearing the alpha-synuclein 3'-untranslated region in primary neurons. These findings reveal a significant additional mechanism by which alpha-synuclein is regulated and point toward new therapeutic regimes for lowering endogenous alpha-synuclein levels in patients with familial or sporadic Parkinson disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
One SNCA SNP (rs17016074) increases transcript levels by >30%, and the other resides within a functional miR-153 binding site.
“SNCA encodes alpha-synuclein, a component of the pathogenic aggregates observed in Parkinson's disease, and one of these SNPs (rs17016074) increases transcript levels by >30% (Sotiriou et al., 2009), whereas the other resides within a functional miR-153 binding site (Doxakis, 2010).”
From Transcriptome-wide Discovery of microRNA Binding Sites in Human Brain (2014) · cites this paper as Doxakis, 2010
Citations
Cites
Combinatorial microRNA target predictions
Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1536 · Cited by 4,603
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
α-Synuclein Is Degraded by Both Autophagy and the Proteasome
Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N., & Rubinsztein, D. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300227200 · Cited by 1,429
Vogiatzi, T., Xilouri, M., Vekrellis, K., & Stefanis, L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801992200 · Cited by 683
Peterson, K. J., Dietrich, M. R., & McPeek, M. A. (2009) · BioEssays · doi:10.1002/bies.200900033 · Cited by 252
Flagged first, then by citations
Research works printed but not linked: 31
- Singleton, 2003, Science, 302, 841, 10.1126/science.1090278 · DOI · Paper page
- Spillantini, 1998, Proc. Natl. Acad. Sci. U.S.A., 95, 6469, 10.1073/pnas.95.11.6469 · DOI · Paper page
- Bennett, 1999, J. Biol. Chem., 274, 33855, 10.1074/jbc.274.48.33855 · DOI · Paper page
- Paxinou, 2001, J. Neurosci., 21, 8053, 10.1523/JNEUROSCI.21-20-08053.2001 · DOI
- Bartel, 2004, Nat. Rev. Genet., 5, 396, 10.1038/nrg1328 · DOI
- Lai, 2005, Curr. Biol., 15, R458, 10.1016/j.cub.2005.06.015 · DOI
- Wienholds, 2005, FEBS Lett., 579, 5911, 10.1016/j.febslet.2005.07.070 · DOI
- Hornstein, 2006, Nat. Genet., 38, S20, 10.1038/ng1803 · DOI · Paper page
- Winkler, 2007, Neurology, 69, 1745, 10.1212/01.wnl.0000275524.15125.f4 · DOI
- Mizuta, 2006, Hum. Mol. Genet., 15, 1151, 10.1093/hmg/ddl030 · DOI
- Simon-Sanchez, 2009, Nat. Genet., 41, 1308, 10.1038/ng.487 · DOI · Paper page
- Sood, 2006, Proc. Natl. Acad. Sci. U.S.A., 103, 2746, 10.1073/pnas.0511045103 · DOI · Paper page
- Ge, 1997, BioTechniques, 22, 28, 10.2144/97221bm03 · DOI
- Raymond, 2005, RNA, 11, 1737, 10.1261/rna.2148705 · DOI
- Lao, 2006, Biochem. Biophys. Res. Commun., 343, 85, 10.1016/j.bbrc.2006.02.106 · DOI
- Doxakis, 2004, Curr. Biol., 14, 1761, 10.1016/j.cub.2004.09.050 · DOI
- Grimson, 2007, Mol. Cell, 27, 91, 10.1016/j.molcel.2007.06.017 · DOI · Paper page
- Enright, 2003, Genome Biol., 5, R1, 10.1186/gb-2003-5-1-r1 · DOI · Paper page
- Eulalio, 2009, RNA, 15, 21, 10.1261/rna.1399509 · DOI
- Mishima, 2006, Curr. Biol., 16, 2135, 10.1016/j.cub.2006.08.086 · DOI · Paper page
- Behm-Ansmant, 2006, Genes Dev., 20, 1885, 10.1101/gad.1424106 · DOI
- Behm-Ansmant, 2006, Cold Spring Harb. Symp. Quant. Biol., 71, 523, 10.1101/sqb.2006.71.013 · DOI
- Trojanowski, 1998, Cell Death Differ., 5, 832, 10.1038/sj.cdd.4400432 · DOI
- Li, 2009, Cell, 137, 273, 10.1016/j.cell.2009.01.058 · DOI · Paper page
- Tessmar-Raible, 2007, Cell, 129, 1389, 10.1016/j.cell.2007.04.041 · DOI · Paper page
- Sathyan, 2007, J. Neurosci., 27, 8546, 10.1523/JNEUROSCI.1269-07.2007 · DOI · Paper page
- Walker, 2006, Alcohol, 38, 1, 10.1016/j.alcohol.2006.03.008 · DOI
- Elmén, 2008, Nature, 452, 896, 10.1038/nature06783 · DOI · Paper page
- Elmén, 2008, Nucleic Acids Res., 36, 1153, 10.1093/nar/gkm1113 · DOI
- Chu, 2007, Neurobiol. Dis., 25, 134, 10.1016/j.nbd.2006.08.021 · DOI
- Krüger, 2006, Nucleic Acids Res., 34, W451, 10.1093/nar/gkl243 · DOI · Paper page
Cited by
Sorted by citations
-Synuclein in Parkinson's Disease
Stefanis, L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009399 · Cited by 1,446
The epigenetics of aging and neurodegeneration
Lardenoije, R., Iatrou, A., Kenis, G., Kompotis, K., Steinbusch, H. W. M., Mastroeni, D., Coleman, P., Lemere, C. A., Hof, P. R., van den Hove, D. L. A., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.05.002 · Cited by 381
Hanan, M., Soreq, H., & Kadener, S. (2017) · RNA Biology · doi:10.1080/15476286.2016.1255398 · Cited by 229
Transcriptome-wide Discovery of microRNA Binding Sites in Human Brain
Boudreau, R. L., Jiang, P., Gilmore, B. L., Spengler, R. M., Tirabassi, R., Nelson, J. A., Ross, C. A., Xing, Y., & Davidson, B. L. (2014) · Neuron · doi:10.1016/j.neuron.2013.10.062 · Cited by 217
Adlakha, Y. K., & Saini, N. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-33 · Cited by 213
Long, J. M., Ray, B., & Lahiri, D. K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.366336 · Cited by 198
Kim, J., Fiesel, F. C., Belmonte, K. C., Hudec, R., Wang, W.-X., Kim, C., Nelson, P. T., Springer, W., & Kim, J. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0121-4 · Cited by 163
“Thus far, a few miRNAs are identified as regulators of PD-associated genes, such as SNCA, LRRK2, and DJ-1 [28–31].”
BackgroundBriggs, C. E., Wang, Y., Kong, B., Woo, T.-U. W., Iyer, L. K., & Sonntag, K. C. (2015) · Brain Research · doi:10.1016/j.brainres.2015.05.021 · Cited by 113
Growth of the Developing Cerebral Cortex Is Controlled by MicroRNA-7 through the p53 Pathway
Pollock, A., Bian, S., Zhang, C., Chen, Z., & Sun, T. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.003 · Cited by 88
MiRNA Profile in the Substantia Nigra of Parkinson’s Disease and Healthy Subjects
Cardo, L. F., Coto, E., Ribacoba, R., Menéndez, M., Moris, G., Suárez, E., & Alvarez, V. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0428-y · Cited by 75
Validation of differentially expressed brain‐enriched microRNAs in the plasma of PD patients
Ravanidis, S., Bougea, A., Papagiannakis, N., Koros, C., Simitsi, A. M., Pachi, I., Breza, M., Stefanis, L., & Doxakis, E. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51146 · Cited by 63
Self-citationCircular RNAs in depression: Biogenesis, function, expression, and therapeutic potential
Gan, H., Lei, Y., Yuan, N., Tang, K., Hao, W., Ma, Q., Wu, M., Zhou, X., Li, X., Huang, J., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111244 · Cited by 41
Bortolozzi, A., Manashirov, S., Chen, A., & Artigas, F. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107873 · Cited by 37
Fu, Y., Zhen, J., & Lu, Z. (2017) · DNA and Cell Biology · doi:10.1089/dna.2017.3643 · Cited by 38
Manecka, D.-L., Vanderperre, B., Fon, E. A., & Durcan, T. M. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00311 · Cited by 21
Metadata
- Authors
- Doxakis, E.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2010-04
- Volume
- 285
- Issue
- 17
- Pages
- 12726-12734
- ISSN
- 0021-9258
- Cited by
- 454
- References
- 5
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review